As recent discoveries provide similar evidence that the deprived serine/glutamine metabolic pathway is lethal for the growth of leukemia cells [38], we believed that the altered cellular metabolic and increased anti-oxidative stress capabilities might be characteristic for DNMT3A R882 mutant clones. The gene discussed is DNMT3A; the disease is leukemia.